Terma
Member
- Joined
- May 8, 2017
- Messages
- 1,063
Maybe one important addendum to your first article:
It's also interesting to note that several years ago members of forums were trying to increase BH4 (oops?). It's synthesized de-novo from purines (GTP) and then recycled. Anyway BH4 does add an interesting angle and it might morph some of my ideas.
Note I reserve the right to adjust these ideas lol because kyn pathway could represent so many states - like a state machine - it's not funny.
Indeed this can be true about kynurenine since it's an important precursor but they can only say this safely if KMO is functional (not NADPH-starved or otherwise) because kynurenine itself surprisingly appears to be an mTorC1 agonist except weaker than tryptophan and without the amino contribution (this gets impossible to follow, because in articles they don't always distinguish properly between kynurenine and its derivatives). Meaning it would be expected to trigger apoptosis only if it lead to a nutrient depletion through mTorC1 (or some other effect) - but that should require higher amounts [of kyn] while nutrient depletion is not quite synonymous with cancer. I think it only safely "disarms" proliferation after KMO consumes the NADPH and goes down the pathway, although the other metabolites also have various of their own effects on the immune system and other cells, and later you end up with more NAD. (I am still unsure how much the NADPH consumption itself alters growth quantitatively, but it is anabolic...)BH4 is also an important candidate for future cancer immunotherapies, as activated T cells sense and fight cancer cells. Analyzing mice, the researchers discovered that higher levels of BH4 activate proliferation of T cells, causing tumors to shrink. Intriguingly, the research team now found that kynurenine, a molecule that can turn off the immune system in tumors, blocks T cell growth – which can be overcome by BH4, allowing T cells to escape local immunosuppression in the tumor environment. "We studied BH4 in pain perception earlier. This is a great example how different fields of research, working together, can make novel discoveries at the interfaces of different kinds of biology”’ says Harvard’s Clifford Woolf. “In our case, a molecule recognized as essential for many functions in neurobiology, is now identified as key for completely novel therapies – when we dial it down we block T cell proliferation in autoimmune diseases or asthma. When we dial it up, we can trigger T cells to grow and attack tumor cells, even under adverse conditions – and hence have discovered a new pathway to induce anti-cancer immunity, one that should greatly expand the effectiveness of the check-point inhibitors currently used". Since the researchers developed a potent and orally available inhibitor, this new concept can soon be tested in human patients.
It's also interesting to note that several years ago members of forums were trying to increase BH4 (oops?). It's synthesized de-novo from purines (GTP) and then recycled. Anyway BH4 does add an interesting angle and it might morph some of my ideas.
Note I reserve the right to adjust these ideas lol because kyn pathway could represent so many states - like a state machine - it's not funny.
Last edited: